Veterinary Medicines

Uristop 40 mg/ml syrup for dogs

Authorised
  • Phenylpropanolamine hydrochloride
Download as PDF

Product identification

Medicine name:
Uristop 40 mg/ml syrup for dogs
Urixine, 40mg/ml, Sirup
Active substance:
  • Phenylpropanolamine hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Phenylpropanolamine hydrochloride
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Syrup
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG04BX91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:
  • Box with 1 bottle of 100 ml and 1 syringe of 1,5 ml
  • Box with 1 bottle of 50 ml and 1 syringe of 1,5 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Karizoo S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
  • Laboratorios Karizoo S.A.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/039/24-C
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0288/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Estonia
  • France
  • Germany
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

English (PDF)
Published on: 5/06/2025
Download
Czech (PDF)
Published on: 17/06/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."